Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2417 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

23 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2022-12-01 2022-12-15 176776
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2022-12-01 2023-04-28 176779
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2022-12-01 2023-04-28 176794
TEVA-NAPROXEN EC 250MG TABLET (ENTERIC-COATED) Resolved 2023-04-27 2023-06-09 190740
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-06-08 2023-06-21 194094
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-07-04 2023-07-14 197052
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-10-05 2023-12-14 206392
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2024-01-11 2024-03-18 215719
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2017-10-10 1748
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2017-10-11 1760
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2018-02-21 1769
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2017-10-10 1778
ACT OXYCODONE CR 5MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-17 2017-09-19 3366
ACT OXYCODONE CR 10MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-17 2017-09-19 3377
ACT OXYCODONE CR 20MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-17 2017-07-01 3381
ACT OXYCODONE CR 80MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-17 2017-09-19 3384
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2017-04-03 2018-02-21 5223
ACT OXYCODONE CR 40MG TABLET (EXTENDED-RELEASE) Resolved 2017-05-24 2017-09-19 10978
TEVA-METHYLPHENIDATE ER-C 18MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-11-24 2020-01-21 30668
TEVA-METHYLPHENIDATE ER-C 27MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-11-24 2020-01-21 30685

Showing 2541 to 2560 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-12 2018-10-12 63943
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-19 2018-10-19 64891
TEVA-TECNAL C 1/4 330MG 50MG 15MG 40MG CAPSULE Discontinued 2019-04-11 2019-04-11 81353

Showing 21 to 40 of 250